Baltimore’s Kennedy Krieger Institute has hired a pediatric and developmental neurologist known for his work using brain scans to research cognitive disabilities as its next president and CEO.
Dr. Bradley L. Schlaggar, who has served on the faculty of Washington University School of Medicine in St. Louis for the past 19 years, will start his new job this summer at the institute, which specializes in disorders and injuries of the brain, spinal cord and musculoskeletal system among children and young adults.
Kennedy Krieger’s board chair, Howard B. Miller, announced the new hire Thursday. Schlaggar was hired after a national search.
“Dr. Schlaggar will be an asset to the team of brilliant minds at Kennedy Krieger who are all dedicated to advancing care, education and research to help the young people we serve,” Miller said. “He is an exemplary physician, researcher and leader.”
Schlaggar succeeds Dr. Gary W. Goldstein, who announced in February that he was retiring after three decades at the helm of Kennedy Krieger. The institute runs an inpatient rehabilitation hospital and outpatient centers. It also operates schools and programs on school campuses. It serves 24,000 patients a year.
For the last four years Schlaggar has served as division head of pediatric and developmental neurology and co-director of the Intellectual and Developmental Disabilities Research Center at Washington University’s medical school. He was also neurologist-in-chief at St. Louis Children’s Hospital. Before that, he directed the hospital’s pediatric neurology residency program for eight years.
His research using neuroimaging, or brain scans, to investigate cognitive development has been recognized with several awards.
He has created brain imaging methods to investigate basic mechanisms in the development of language, reading, attention and executive control, according to his profile on the Washington University website. He has looked at these issues in healthy children and those whose cognitive skills are delayed by strokes or illness, including Tourette Syndrome.